<DOC>
	<DOCNO>NCT00421018</DOCNO>
	<brief_summary>The purpose study determine whether use exhale NO ( nitric oxide ) regulate anti-inflammatory treatment lead increase asthma-related quality life patient allergic asthma</brief_summary>
	<brief_title>Optimization Asthma Treatment Through Exhaled NO Increased Asthma-Related Quality Life ( NOAK )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>Age 1864 Clinical diagnosis Asthma Glucocorticoid treatment &gt; 6 month . Verified Allergy Read speak Swedish Smoking Current regular treatment longacting beta2agonist Treatment Singulair combination glucocorticoid Taking part research study Pregnancy breastfeed Unstable Asthma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Allergy</keyword>
	<keyword>Cytokines</keyword>
	<keyword>Glucocorticoids</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Nitric Oxide ( NO )</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Self-Rated Health</keyword>
	<keyword>Stress</keyword>
</DOC>